Nanomedicine News

RSS

Innovative Nanotechnology-Based Approach Prevents Inflammation-Induced Damage

Doses of medicine 100,000 times smaller than the diameter of a human hair prevent the tissue damage associated with atherosclerosis and other chronic diseases in mice.

11 Apr 2013

Novel Nanoparticle-Based Approach Enables More Efficient Delivery of siRNA Drugs

New classes of drugs that can silence specific genes, such as small interfering RNAs (siRNAs), offer great therapeutic potential. But the specific delivery of siRNAs to target cells to exert their effects remains a significant challenge.

11 Apr 2013

BIND Therapeutics Announces Positive Phase 1 Clinical Data for Nanomedicine, BIND-014

BIND Therapeutics, a clinical-stage biopharmaceutical company developing a new class of highly selective targeted and programmable therapeutics called Accurins™, announced today that positive Phase 1 clinical data for BIND-014, the company’s lead drug candidate, were presented today in an oral presentation at the American Association for Cancer Research (AACR) 2013 Annual Meeting.

11 Apr 2013

Manhattan Scientifics Receives Fund to Develop First Generation of Nanomagnetic Relaxometry

Manhattan Scientifics announced today that it has received the initial $1 million of a $2.5 million commitment to build the first generation of its advanced cancer detection devices. More information can be found in the company’s recent 8-K filing.

From Manhattan Scientifics Inc. 11 Apr 2013

mPhase Seeks Licensing Opportunities for Nanotechnology-Inspired Drug Delivery System

mPhase Technologies, Inc. said today that it is pursuing licensing opportunities for its Smart Drug Delivery System. mPhase recently filed a United States Letter Patent application for its novel drug delivery system based on its Smart Surface technology.

From MyPebble 10 Apr 2013

Experimental Cancer Photothermal Therapy Using Gold Nano-Bullets

Cutting edge research into an experimental therapy that deploys nano-particles of gold in the fight against cancer earned an Alberta high school student, 16, top national honours today in the 2013 "Sanofi BioGENEius Challenge Canada" (SBCC).

10 Apr 2013

Tekmira Announces Phase I Results of Lipid Nanoparticle-Based TKM-PLK1 RNAi Therapeutic

Tekmira Pharmaceuticals Corporation, a leading developer of RNA interference (RNAi) therapeutics, announced the results of its Phase I clinical trial with TKM-PLK1, an RNAi therapeutic for the treatment of solid tumors.

10 Apr 2013

Nanotechnology-Inspired Cancer-Detection Instrument Extends Market Reach

A device co-developed by a University of Houston (UH) physicist to detect the spread of breast cancer and allow physicians to better plan intervention is extending its market reach, bringing it another step closer to clinical trials in the U.S.

10 Apr 2013

NanoSight's Nanoparticle Tracking Analysis Used for Cancer Research at Trinity College Dublin

NanoSight reports on how Nanoparticle Tracking Analysis, NTA, is being applied in the development of future diagnostic and theranostic solutions for early diagnosis, drug delivery and treatment of cancer at the School of Medicine and CRANN, Trinity College Dublin, Ireland.

9 Apr 2013

BfArM Permits MagForce to Begin Post-Marketing Study in Glioblastoma with NanoTherm Therapy

MagForce AG / MagForce AG Receives BfArM Approval to Start the Post-Marketing Study in Glioblastoma with NanoTherm® Therapy.

From MagForce Nanotechnologies AG 9 Apr 2013

Nanomedicine News

Innovative Nanotechnology-Based Approach Prevents Inflammation-Induced Damage

Novel Nanoparticle-Based Approach Enables More Efficient Delivery of siRNA Drugs

BIND Therapeutics Announces Positive Phase 1 Clinical Data for Nanomedicine, BIND-014

Manhattan Scientifics Receives Fund to Develop First Generation of Nanomagnetic Relaxometry

mPhase Seeks Licensing Opportunities for Nanotechnology-Inspired Drug Delivery System

Experimental Cancer Photothermal Therapy Using Gold Nano-Bullets

Tekmira Announces Phase I Results of Lipid Nanoparticle-Based TKM-PLK1 RNAi Therapeutic

Nanotechnology-Inspired Cancer-Detection Instrument Extends Market Reach

NanoSight's Nanoparticle Tracking Analysis Used for Cancer Research at Trinity College Dublin

BfArM Permits MagForce to Begin Post-Marketing Study in Glioblastoma with NanoTherm Therapy

Enhanced Antibacterial Polylactic Acid-Curcumin Nanofibers for Wound Dressings

Gold Nanoparticles to Restore Vision in Retinal Disorders

Levidian and Zentek Seek to Establish Graphene-Integrated Filter Manufacturing Facility in the Middle East to Advance Cleaner, Safer Air

Scalable Method for Porous Graphene Membranes for CO2 Capture

Biochar-Modified Titanium Dioxide Nanocomposites for Enhanced Water Treatment

Overcoming Nanogold Production Challenges

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Sponsored Content

Utilizing Back-Gate Voltage Biases for 2D Materials

Resistivity Metrology for Sputtered ITO Thin Films

How Plasma Cleaning Technology Tackles Hydrocarbon Contamination

Optimizing EV Lubricants with Electrified Tribotesting